GT Biopharma (GTBP)

• Market cap: $7.45M
• 1 day: -2.78%
• 5 days: 0%
• 1 month: 1.85%
• 3 months: -11.3%
• 6 months: -75%
• Year to date: -76.19%
• 1 year: -71.89%
• 5 years: -99.55%
• 10 years: -99.55%
• Sector: Healthcare
• Industry: Biotechnology

About: GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Employees: 1